Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pirbright partners on projects to develop PRRS vaccines
PRRSV is responsible for one of the most damaging diseases to the global pig industry.
Disease costs pig farmers in Europe an estimated €1.5 billion a year. 

The Pirbright Institute has announced that it is joining forces with ECO Animal Health and The Vaccine Group (TVG) in two projects to develop new vaccines for porcine respiratory and reproductive syndrome virus (PRRSC).

PRRSV (type-1 and type -2) is responsible for one of the most damaging diseases to the global pig industry, costing pig farmers in Europe an estimated € 1.5 billion a year and those in the US some $600 million.

The first project will see Pirbirght test two vaccine candidates that use TVG's vaccine technology to assess their effectiveness at tackling PRRSV in pigs. The vaccines are created by using TVG technology to insert non-infectious conserved PRRSV genes supplied by Pirbright into a benign herpesvirus, which then stimulates the immune system when delivered into animals.

Professor Simon Graham, group leader of PRRS Immunology at The Pirbright Institute said, said: “This is an exciting project that takes a novel approach to addressing the urgent requirement for improved vaccines to combat the global spread of PRRSV.”

Associate Professor Dr Michael Jarvis, TVG founder and chief scientific officer,  said: “This is an exciting opportunity that brings together critical basic science and translational expertise towards addressing this major infectious disease in pigs. As PRRSV is a member of the Nidovirus group of viruses, a group that also contains SARS-CoV-2, what we learn from development of a PRRSV vaccine may also help inform our development of a vaccine against SARS-CoV-2.”

In the second project, Pirbright will work with ECO to develop a significantly improved killed vaccine over 18 months. The team will generate modified PRRSV strains and then inactivate them to create vaccine candidates.

Dr Hafid Benchaoui, head of global R&D at the ECO Animal Health Group added: “ECO Animal Health recognises the significant, ongoing challenge that PRRSV poses for pig producers all over the world. This collaboration with The Pirbright Institute and The Vaccine Group leverages the deep scientific expertise of The Pirbright Institute and The Vaccine Group’s novel herpesvirus vector technology in an exciting new approach to PRRSV vaccination.”

Become a member or log in to add this story to your CPD history

Vets asked to opt-in to Scottish SPCA fostering programme

News Story 1
 The Scottish SPCA is encouraging veterinary practices to opt into its new fostering programme, by agreeing to register foster animals when approached by one of the foster carers.

The programme goes live in August 2021, and will help to rehabilitate animals under the Scottish SPCA's care until they are able to be properly re-homed. The programme will help the animals to receive care and attention in a stable and happy home environment, as some animals do not cope with a rescue and re-homing centre environment as well as others.

Specific information for veterinary practices on the new programme can be found at www.scottishspca.org/veterinarysurgeons 

Click here for more...
News Shorts
Webinar provides insight into old age pets

A new webinar providing insights into the BSAVA PetSavers Old Age Pets citizen science project is now available free of charge to its members via the BSAVA Library

The webinar presents an exclusive insight into the research process and progression of the study, which aims to help veterinary professionals and owners provide the best care for their senior dogs.

It also discusses the study's research methods, the researchers' personal interests in this area of study, and how they envisage the findings being used to create a guidance tool to improve discussions between vets and owners about their ageing dogs.